Johansen OE - Search Results

1

Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials.

Lehrke M, Leiter LA, Hehnke U, Thiemann S, Bhandari A, Meinicke T, Johansen OE. Lehrke M, et al. Among authors: johansen oe. J Diabetes Complications. 2016 Sep-Oct;30(7):1378-84. doi: 10.1016/j.jdiacomp.2016.06.015. Epub 2016 Jun 16. J Diabetes Complications. 2016. PMID: 27396241 Free article. Clinical Trial.

2

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.

Johansen OE, Neubacher D, von Eynatten M, Patel S, Woerle HJ. Johansen OE, et al. Cardiovasc Diabetol. 2012 Jan 10;11:3. doi: 10.1186/1475-2840-11-3. Cardiovasc Diabetol. 2012. PMID: 22234149 Free PMC article.

3

Activin A and cardiovascular disease in type 2 diabetes mellitus.

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE. Ueland T, et al. Among authors: johansen oe. Diab Vasc Dis Res. 2012 Jul;9(3):234-7. doi: 10.1177/1479164111431171. Epub 2012 Jan 10. Diab Vasc Dis Res. 2012. PMID: 22234949 Free article.

4

C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.

Johansen OE, Boehm BO, Grill V, Torjesen PA, Bhattacharya S, Patel S, Wetzel K, Woerle HJ. Johansen OE, et al. Diabetes Care. 2014;37(1):e11-2. doi: 10.2337/dc13-1523. Diabetes Care. 2014. PMID: 24356601 Clinical Trial. No abstract available.

5

Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.

Lehrke M, Marx N, Patel S, Seck T, Crowe S, Cheng K, von Eynatten M, Johansen OE. Lehrke M, et al. Among authors: johansen oe. Clin Ther. 2014 Aug 1;36(8):1130-46. doi: 10.1016/j.clinthera.2014.06.008. Epub 2014 Jul 8. Clin Ther. 2014. PMID: 25015594 Free article.

6

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®).

Marx N, Rosenstock J, Kahn SE, Zinman B, Kastelein JJ, Lachin JM, Espeland MA, Bluhmki E, Mattheus M, Ryckaert B, Patel S, Johansen OE, Woerle HJ. Marx N, et al. Among authors: johansen oe. Diab Vasc Dis Res. 2015 May;12(3):164-74. doi: 10.1177/1479164115570301. Epub 2015 Mar 15. Diab Vasc Dis Res. 2015. PMID: 25780262 Free PMC article. Clinical Trial.

7

Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.

Rosenstock J, Marx N, Neubacher D, Seck T, Patel S, Woerle HJ, Johansen OE. Rosenstock J, et al. Among authors: johansen oe. Cardiovasc Diabetol. 2015 May 21;14:57. doi: 10.1186/s12933-015-0215-2. Cardiovasc Diabetol. 2015. PMID: 25990013 Free PMC article.

8

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).

Pieber TR, Famulla S, Eilbracht J, Cescutti J, Soleymanlou N, Johansen OE, Woerle HJ, Broedl UC, Kaspers S. Pieber TR, et al. Among authors: johansen oe. Diabetes Obes Metab. 2015 Oct;17(10):928-35. doi: 10.1111/dom.12494. Epub 2015 Jun 24. Diabetes Obes Metab. 2015. PMID: 26080652 Free PMC article. Clinical Trial.

9

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE. Chilton R, et al. Among authors: johansen oe. Diabetes Obes Metab. 2015 Dec;17(12):1180-93. doi: 10.1111/dom.12572. Epub 2015 Oct 9. Diabetes Obes Metab. 2015. PMID: 26343814 Free PMC article. Clinical Trial.

10

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.

Zinman B, Ahrén B, Neubacher D, Patel S, Woerle HJ, Johansen OE. Zinman B, et al. Among authors: johansen oe. Can J Diabetes. 2016 Feb;40(1):50-7. doi: 10.1016/j.jcjd.2015.06.010. Epub 2015 Oct 21. Can J Diabetes. 2016. PMID: 26474870 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters